|BIOVF -- USA Stock|| |
USD 26.80 0.000001 0.00%
Mr. Stefan Fraenkel serves as Senior Vice President, Head of Corporationrationrate Development at Swedish Orphan Biovitrum AB . He joined the Company in 2009. He is also Board member of Akinion Pharmaceuticals. He was Management Consultant and has held several international managerial positions within Wyeth Pharmaceuticals 20012009
Age: 43 MBA
46 86 97 20 00 http://www.sobi.com
Fraenkel holds a Doctorate of Philosophy degree in International Accounting and Management. Apart from that, he has obtained a MBA degree from Copenhagen Business School and a BS degree in Engineering from Chalmers Tekniska Hogskola.